Profile data is unavailable for this security.
About the company
Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.
- Revenue in HKD (TTM)281.11m
- Net income in HKD-236.90m
- Incorporated2018
- Employees429.00
- LocationAlphamab OncologyNo. 175Fangzhou Road, Suzhou Industrial ParkSuzhou 215125ChinaCHN
- Phone+86 51 262850800
- Websitehttps://www.alphamabonc.com/en/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wuhan YZY Biopharma Co Ltd | 0.00 | -201.63m | 1.20bn | 114.00 | -- | 21.95 | -- | -- | -1.06 | -1.06 | 0.00 | 0.281 | 0.00 | -- | -- | 0.00 | -83.99 | -- | -230.17 | -- | -- | -- | -- | -- | 1.21 | -44.35 | 0.7078 | -- | -- | -- | -1.50 | -- | -- | -- |
Hua Medicine | 119.69m | -289.36m | 1.20bn | 172.00 | -- | -- | -- | 10.05 | -0.2952 | -0.2952 | 0.1221 | -0.0372 | 0.0779 | 1.51 | 1.90 | 676,207.60 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Frontage Holdings Corp | 2.03bn | 47.53m | 1.24bn | 1.66k | 26.54 | 0.4735 | 3.67 | 0.613 | 0.023 | 0.023 | 0.9892 | 1.29 | 0.4701 | 56.23 | 4.18 | 1,151,734.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.19 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
Mabpharm Ltd | 166.58m | -227.34m | 1.26bn | 347.00 | -- | 9.94 | -- | 7.55 | -0.0551 | -0.0551 | 0.0404 | 0.0307 | 0.164 | 0.1937 | 3.26 | 480,061.10 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -23.09 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Immunotech Biopharm Ltd | 0.00 | -339.72m | 1.37bn | 211.00 | -- | 15.42 | -- | -- | -0.6602 | -0.6602 | 0.00 | 0.1732 | 0.00 | -- | -- | 0.00 | -35.21 | -37.42 | -55.75 | -45.48 | -- | -- | -- | -- | 0.3638 | -2.44 | 0.6119 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
Jacobio Pharmaceuticals Group Co Ltd | 25.47m | -397.59m | 1.41bn | 298.00 | -- | 1.42 | -- | 55.16 | -0.5122 | -0.5122 | 0.0328 | 1.26 | 0.016 | -- | 2.41 | 84,624.98 | -24.89 | -45.76 | -28.66 | -49.30 | 3.45 | -- | -1,560.88 | -372.22 | -- | -- | 0.1794 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
TOT Biopharm International Co Ltd | 1.07bn | 9.85m | 1.45bn | 551.00 | 138.45 | 1.83 | 20.83 | 1.36 | 0.0136 | 0.0136 | 1.47 | 1.03 | 0.6899 | 2.44 | 6.35 | 1,940,415.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
Laekna Inc | 0.00 | -324.69m | 1.71bn | 92.00 | -- | 2.31 | -- | -- | -0.9112 | -0.9112 | 0.00 | 1.90 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
CARsgen Therapeutics Holdings Ltd | 6.97m | -763.43m | 1.77bn | 477.00 | -- | 1.08 | -- | 253.55 | -1.37 | -1.37 | 0.0125 | 2.86 | 0.0027 | -- | 0.302 | 13,498.87 | -29.27 | -- | -32.86 | -- | 25.50 | -- | -10,960.25 | -- | 9.44 | -- | 0.1246 | -- | -- | -- | 16.19 | -- | -- | -- |
CStone Pharmaceuticals | 501.57m | -156.35m | 1.96bn | 164.00 | -- | 3.82 | -- | 3.92 | -0.1227 | -0.1227 | 0.3934 | 0.4001 | 0.2861 | 1.33 | 2.50 | 2,180,732.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
Abbisko Cayman Ltd | 546.33m | -17.80m | 2.11bn | 275.00 | -- | 0.92 | 582.03 | 3.87 | -0.0302 | -0.0302 | 0.8412 | 3.35 | 0.2159 | -- | -- | 2,117,548.00 | -0.7034 | -- | -0.733 | -- | 100.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 2.12bn | 145.00 | -- | 3.21 | -- | -- | -- | -- | -- | 1.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
Alphamab Oncology | 281.11m | -236.90m | 2.37bn | 429.00 | -- | 1.33 | -- | 8.44 | -0.2461 | -0.2461 | 0.292 | 1.85 | 0.1145 | 0.8256 | 13.94 | 646,231.50 | -9.65 | -18.72 | -11.16 | -21.94 | 79.33 | -- | -84.27 | -415.55 | 4.42 | -- | 0.167 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
Biocytogen Pharmaceuticals Beijng Co Ltd | 879.55m | -267.87m | 2.66bn | 1.04k | -- | 3.27 | -- | 3.02 | -0.6726 | -0.6726 | 2.21 | 2.03 | 0.3109 | 23.64 | 5.35 | 825,092.80 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -3.22 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
Data as of Sep 17 2024. Currency figures normalised to Alphamab Oncology's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 04 Sep 2024 | 23.84m | 2.47% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 16.02m | 1.66% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 12.24m | 1.27% |
First Seafront Fund Management Co., Ltd.as of 31 Dec 2023 | 8.52m | 0.88% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 7.75m | 0.80% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 2.19m | 0.23% |
E Fund Asset Management Co. Ltd.as of 30 Jun 2024 | 1.34m | 0.14% |
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 1.18m | 0.12% |
SSgA Funds Management, Inc.as of 05 Sep 2024 | 737.00k | 0.08% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 636.00k | 0.07% |
More ▼
Data from 31 Dec 2023 - 12 Sep 2024Source: FactSet Research Systems Inc.